Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2008
May 1, 2008
- ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
- Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
- Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
- Coversyl Protects Hypertensive Patients Against New-onset Diabetes
- New Study Raises Questions About Prostate Cancer Therapies Targeting Insulin-Like Growth Factor Receptor
- Resolvyx Compounds Show Promise In Treatment of Ocular Disease
- Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
May 2, 2008
- BioLineRx Presents BL-1020 Phase 2a Data at Society of Biological Psychiatry 63rd Annual Scientific Convention & Meeting
- Celgene Cellular Therapeutics Announces Clinical Transplant of Human Placenta-Derived Stem Cells
- Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
- Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
- Somaxon Pharmaceuticals Announces Data to Be Presented at American Psychiatric Association 161st Annual Meeting
- IRX Therapeutics to Present Phase 2b Results at 3rd European Conference on Head & Neck Oncology
- Asphelia to Present At Digestive Disease Week 2008 in San Diego
- Four Out of Five High Blood Pressure Related Deaths Occur in Developing World
- More Than a Quarter of Americans Experience Pain
May 5, 2008
- BioDelivery Sciences Presenting Phase III Data on BEMA Fentanyl at American Pain Society Meeting
- Anti-HIV NanoViricide Drug Candidate Demonstrates Significant Therapeutic Efficacy in Animal Trials
- Anesiva Announces Publication of Phase 3 Zingo Data in the Journal Pediatrics
- QLT completes enrollment in the RADICAL study
- YM Biosciences Announces Presentations for Aerolef at American Pain Society Annual Meeting
- Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
- Results Published in JACC Show Clinical Advantage of Switching to Angiomax from Heparin in Acute Coronary Syndrome Patients Undergoing Early Invasive Treatment
- Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
- N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201
- Can-Fite Successfully Completed Phase I Clinical Trial with its 2nd Drug CF102
- Efficacy of FluMist in Children Highlighted at Pediatric Academic Societies Meeting
- Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
- A Safer Alternative to Aspirin?
- Kidney Disease Substantially Worsens in a Fourth of African Americans Despite Therapy for Hypertension
- Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva in the Treatment of Psoriasis Published in the British Journal of Dermatology
- QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
- Divigel (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
- Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid in Facial Augmentation
- New Data on Seroquel XR in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
May 6, 2008
- Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
- Affitech Announces Achievement of Significant Milestone in Antibody Discovery Collaboration
- NicOx announces U.S. phase 2a results for PF-03187207 and gives an update on continuing NO-prostaglandin program
- Novartis Menveo Vaccine Shows Superior Immune Response Against Four Types of Meningitis Disease in Pivotal Phase III Trial
- Two Year Study Confirms Supprelin LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty
- YM Biosciences Announces Schedule of Nimotuzumab Presentations at ASCO 2008 Annual Meeting
- New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
- New Study Confirms Dose-Accuracy of SoloSTAR Prefilled Insulin Pen
- Early Study Results Show New Stem Cell Treatment Successfully Treats Critical Limb Ischemia (CLI) Patients
- Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
- Clinical Data, Inc. Presents Vilazodone Data at 2008 Annual Meeting of the APA
- Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
May 7, 2008
- Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
- LifeCycle Pharma Announces Positive Data from LCP-AtorFen Phase II Clinical Program
- Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
- ACE-011 Preclinical Data Published in the Proceedings of the National Academy of Sciences
- NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
- The Nation's Leading Plastic Surgeons Learn about ArteFill's Five Year Safety and Long-Term Efficacy Data
- Steroids Provide No Survival Benefit for Children With Bacterial Meningitis
- Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting
- XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
- Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting
- New data demonstrate that risperidone long-acting injection extends time to relapse in patients with schizophrenia compared to those treated with oral quetiapine
- Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
- Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
- New Analysis in Boys and Girls Shows the ADHD Patch, Daytrana (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
- Shire's Investigational Nonstimulant ADHD Treatment Intuniv (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
- Study Demonstrates Lexapro Significantly Improves Depression Symptoms in Adolescents
- iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
- Clinical Data on Somaxon Pharmaceuticals' Product Candidate for the Treatment of Insomnia Presented at American Psychiatric Association Annual Meeting
- Savient Reports Favorable Interim Data from Puricase (pegloticase) Open Label Extension Study
May 8, 2008
- Discovery Labs Presents Surfaxin Data At Pediatric Academic Societies Annual Meeting
- KeyNeurotek Pharmaceuticals Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist
- Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
- Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific Meeting
- New Abbott Study of Investigational Vicodin CR Meets Primary Efficacy Endpoints in Phase III Trial
- New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
- Discovery Labs KL-4 Surfactant Technology Displays Antimicrobial Properties and Does Not Induce Immune Response in Preclinical Models
- BEMA(TM) Fentanyl Phase III Data Demonstrating Efficacy and Tolerability to be Presented at American Pain Society Annual Meeting
- GATTEX Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session
- Aethlon Medical Releases Smallpox Related Research Data
- Data Show FLECTOR Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
- Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora Significantly Relieves Short-Term Anxiety in Healthy Women
- Results of the Phase III Pivotal Study of Vyvanse (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
- Collegium Pharmaceutical Inc. Presents Clinical Data for DETERx Abuse-Deterrent Sustained Release Technology at American Pain Society Meeting
- Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
- BioDelivery Sciences Presents Phase III BEMA Fentanyl Data
- Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
May 9, 2008
May 12, 2008
- Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
- Lunesta Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry
- Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia
- New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
- Starpharma Holdings Limited Reports Positive VivaGel Clinical Study Results
- Tengion to Present Preclinical Data For Regeneration of Entire Bladder
- Bone Medical further positive results from oral osteoporosis drug trial
- Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
- NovaBay's Lead Aganocide Compound, NVC-422, Well Tolerated in the Bladder in Phase I Trial
- Novelos Therapeutics Announces Positive Results in Ongoing Phase 2 Neoadjuvant Breast Cancer Trial at MUSC Hollings Cancer Center
- Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
- Repros Therapeutics Inc. Announces That Proellex Shows No Adverse Cardiac Effects In A Pilot Trial
- Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
May 13, 2008
- Ardana Announces a Preliminary Evaluation of Its Testosterone Cream Pivotal Study and Provides an Update on Various Strategic Options
- AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
- Valeant Announces Successful Completion of Retigabine Phase III Epilepsy Program Validating Novel Mechanism of Action
- XIENCE V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
- ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent
- Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children
- Peregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
- SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS and TAXUS Express Stents
- XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
- Novel Treatment Offers Insomnia Sufferers Hope of Quality Sleep
- TAXUS Express Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
May 14, 2008
- Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
- Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
- Significant Blood Pressure Reductions Seen in Difficult-to-Treat, Black Patients Receiving Exforge-based Therapy
- In a Phase II Study, Novartis Meningitis B Vaccine Has Potential to Produce a Protective Immune Response in Infants, the Age Group Most at Risk
- Cervarix Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
- Lipid Sciences' Atherosclerosis Regression Data Presented at EuroPCR 2008 Congress
- New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with Benicar and Benicar HCT
- PRoFESS Results Announced at XVII European Stroke Conference
- Regenerative Medicine Offers Hope in Spinal Cord Injury
- Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
- Ambrilia Biopharma Announces Positive Phase III Results - Octreotide C2L
May 15, 2008
- IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
- Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
- Allos Therapeutics Reports Interim Response and Safety Data from Pivotal Phase 2 PROPEL Trial
- Avelox Monotherapy Shows Strong Performance in Treating Hospitalized Pneumonia Patients
- Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
- New data show Tekturna HCT is twice as effective at reducing blood pressure than the diuretic HCT alone
- Adherex Announces Publication of ADH-1 Study in Cancer Research
- Oculus Innovative Sciences to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto
- New Hypertension Data Coming Out Of The American Society of Hypertension Annual Meeting From Daiichi Sankyo
- Cerenis Therapeutics Announces Successful Completion of Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
- Tioga Pharmaceuticals to Present Asimadoline Phase 2b Data in Irritable Bowel Syndrome at Digestive Disease Week 2008 Annual Meeting
- New Data on Bristol-Myers Squibb Oncology Compounds to Be Featured in More Than 100 Abstracts at ASCO 2008
- CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
- Novel Microparticle Offers Immunological Breakthrough Against a Range of Infectious Diseases and Potentially Some Cancers
- Women Underestimate Their Risk of Spinal Fractures from Osteoporosis, Reveals a Spine-health.com Study
- Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
- Independent Clinical Investigators to Present Data on Nymox BPH Drug at American Urological Association Meeting in Chicago September 25
- Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
- International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population
- Landmark ATHENA Study Findings With Multaq (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
- Azor Reduces Blood Pressure in Difficult to Treat Special Populations
- Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
- Researchers Report Thymosin B4 Promotes Spinal Cord Nerve Cell Survival and Neurite Outgrowth
May 16, 2008
- Dynavax TOLAMBA Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook
- ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
- Callisto Pharmaceuticals Reports Promising Interim Phase II Data for Atiprimod in Advanced Carcinoid Cancer
- Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
- Medarex Announces June 2nd Webcast Review and Discussion of Ipilimumab Data Presented at ASCO
- 75 Abstracts Evaluating Celgene Products to Be Presented at The 44th American Society of Clinical Oncology Meeting
- Molecular Insight Pharmaceuticals, Inc. To Present Interim Phase 1 Data at ASCO on Azedra in Malignant Pheochromocytoma/Paraganglioma Patients
- Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting
- BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
- Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
- OncoGenex reports updated survival data on OGX-011 in a second-line chemotherapy trial for patients with prostate cancer
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online at ASCO.org
- GSK Announces Results of First Phase III Trial Evaluating Tykerb/Tyverb (lapatinib) Plus Herceptin (trastuzumab)
- ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety Profile of Its Oral Investigational mTOR Inhibitor, Deforolimus
- Genentech Provides Update on Studies of Investigational Biooncology Agents to Be Presented at the American Society of Clinical Oncology Meeting
- New Data Highlighting the Potential Utility of ABRAXANE in Combination with Targeted Therapies and Other Chemotherapeutic Agents to Be Presented at ASCO
- Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent
- Dynavax to Discuss TOLAMBA Chamber Data; Update 2008 Outlook in Webcast This Morning
- MolMed to present Phase II trial preliminary results for its anticancer therapeutic Arenegyr at ASCO Annual Meeting 2008
- New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
- Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
- Renhuang Pharmaceuticals, Inc. Co-Sponsors Sino-German Workshop on Sleep Research
- Seattle Genetics Announces Upcoming SGN-35 Presentation at the American Society of Clinical Oncology Annual Meeting
- Erbitux (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
- Significant Data on Erbitux (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinical Oncology 2008 Annual Meeting
- Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
- New Pfizer Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at ASCO
- Amgen Highlights Data to Be Presented at ASCO
- Genentech Provides Update on Avastin Program
- Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
- IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
- CLSI Publishes Updated Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi
- Iressa Shows Promise For Treatment of Metastatic Breast Cancer When Combined With Hormonal Therapy
- Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
- New Drug Combination Brings One-Two Punch Against Acute Leukemia
- New Data Support High Complete Remission Rates With Velcade (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
May 19, 2008
- NovaBay (NBY) Announces Positive Results From Phase IIA Study of AgaNase For Nasal Decolonization of Staph including MRSA
- Spectrum Pharmaceuticals to Present Phase 2 Data on Ortataxel in Breast Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
- NanoViricides' EKC Eye Drug Demonstrates Significant Therapeutic Efficacy in Initial Animal Trials
- RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients with Advanced Kidney
- Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
- Phenomix Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes
- Advair Reduces Exacerbations in COPD Patients With a History of Exacerbations
- Additional Digestive Disease Week Data Highlight Effects of Amitiza in patients with IBS-C
- RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients with Advanced Kidney Cancer
- Positive Clinical Data with Santarus' Zegerid Capsules in Controlling 24-Hour Gastric Acidity Presented in DDW Abstract
- Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
- Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
- TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
- Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes
- Adherex Announces ASCO Abstract of ADH-1 in Melanoma
- Researchers Report Thymosin B4 Protects Human Cornea Epithelial Cells Against Oxidative Damage
- Pozen Announces PN 200 Podium Presentation at Digestive Disease Week
- Study Identifies Novel Glycan Markers, Anti-L & Anti-C, That Predict Aggressive Crohn's Disease and Improve Differentiation Between Crohn's Disease and Ulcerative Colitis
- Argos Therapeutics Discusses Novel Solutions for Automated Immunotherapy Manufacturing at ISCT Annual Meeting
- Ark Makes Significant Advances with EG013 and EG014 Preclinical Programmes
- Pegasys/Copegus Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
- Infant Primates Given Vaccines on U.S. Children's Immunization Schedule Develop Biomedical and Behavioral Symptoms of Autism
- ASCO Selects 28 Sarah Cannon Studies for Presentation at Annual Meeting
- ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
- RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
- Transgene Announces Promising Phase I Preliminary Results of Its HCV Therapeutic Vaccine
- ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity in Metastatic Pancreatic Cancer
- Phase 3 Gattex Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
- VioQuest Pharmaceuticals Announces Upcoming Lenocta Oral Presentation at the American Society of Clinical Oncology Annual Meeting
- Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL
- Amikacin Inhale Shows Promising Results in Phase II Study
May 20, 2008
- Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
- Compugen Presents Experimental Results for Three G-Protein Coupled Receptor (GPCR) Ligands
- KAI Pharmaceuticals Advances Third Product Candidate into Clinical Studies
- ImmuPharma’s Cancer Drug Candidate IPP- 204106 Shows Complete Response to Tumours in Multiple Human Cancer Cell Lines
- Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
- Halozyme Therapeutics Presents Pre-Clinical Studies on Dermal Remodeling With HTI-501, a Lysosomal Proteinase
- Protox to present BPH data at AUA Conference
- Medication May Prevent Depression in Patients with Head and Neck Cancer
- Delayed Adverse Effects May Occur Following Injection with Cosmetic Skin Fillers
- Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO
- Dynogen Presents Results of Its Positive Phase 2 IBS-d Study with DDP225
- Ceragenix Announces Results of a Comparison Study of the Safety and Efficacy of EpiCeram Cream for the Treatment of Mild to Moderate Pediatric Atopic Dermatitis
- Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair Than Doubling the Dose of ICS
- New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
- Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
- Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-naïve Patients with Metastatic Melanoma
- Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting
- Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
- Therapeutic DNA Vaccine Company Inovio Biomedical to Present at Upcoming Scientific Conferences
- Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
- Gilead Announces New Letairis (Ambrisentan) Data for the Treatment of Patients With Pulmonary Arterial Hypertension (WHO Group 1) With WHO Functional Class II or III Symptoms
- Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of Lialda (mesalamine) Presented at DDW
- New Analysis Shows Efficacy of Remicade in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
- Balsalazide 3.3 Grams Twice-Daily Shows Significant Improvement in Bowel Function and Some Quality of Life Measures as Early as Week Two
- Dynogen Presents Results of Its Positive Phase 2a IBS-c Study with DDP733
- Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant and Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (D-IBS)
- Ceftobiprole shows high cure rates in patients hospitalized with community-acquired pneumonia
- Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
- Study Analyzed Symbicort in Children with Persistent Asthma
- Newly-Approved Cimzia Provides Rapid, Sustained Response in Crohn's Patients
May 21, 2008
- Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
- Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
- Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
- Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
- Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
- Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American Urological Association
- Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
- Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week
- Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer
- Excellent clinical trial data from Photocure's photodynamic diagnostic Lumacan
- Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics
- Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
- Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
- PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
- Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
- Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
- ATHENA Clinical Results for Dronedarone (Multaq) Highlighted at the World Cardiology Congress
- QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
- Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
- ImmunoCellular Therapeutics Announces Completion of Proof-of-Principle Studies Demonstrating Efficacy of Cancer Stem Cell Vaccine in Preclinical Model
- Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
- Sanofi-aventis and Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program in Oncology
- Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With Humira (Adalimumab) Maintained Remission
- Three-Year COPD Study Found No Increase in Cardiac Events With Advair 500/50
- Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of Polycystic Kidney Disease
May 22, 2008
- Wyeth and Progenics Announce Preliminary Clinical Trial Results for Relistor Oral and Intravenous Formulations
- AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting
- Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
- New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
- Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
- Cougar Biotechnology to Present Clinical Data on CB7630 (Abiraterone Acetate) at American Society of Clinical Oncology 2008 Annual Meeting
- Caphosol Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
- Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the International Society of Cell Therapy Annual Meeting
- Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
- QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy
- Nearly 60 New Studies of Oral Xeloda (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
- Stabilizing Cancer-Fighting p53 Can Also Shield a Metastasis-Promoter
- Anti-rejection Drug May Increase Risk of Diabetes After Kidney Transplant
- Rexin-G Monotherapy Reveals Significant Biological Activity without Toxicity in Chemo-Resistant Metastatic Breast Cancer
- Tioga Pharmaceuticals’ Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
- Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
May 27, 2008
- Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
- Osteologix Presents Phase 2 Osteoporosis Data at a Major European Medical Conference
- Isotechnika reports final results of the PROMISE trial
- ImmunoGen, Inc. Announces Presentations at Upcoming 2008 American Society of Clinical Oncology Annual Meeting
- Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
- AVANIR Announces Positive Outcome of Zenvia PK Study
- Neose Announces Two Abstracts on GlycoPEGylated Factor VIIa Accepted for Presentation at the Hemophilia 2008 World Congress
- ThromboGenics Presents Further Results of the Vitreomacular Traction Trial (MIVI IIT) at the Euretina Annual Meeting in Vienna
- Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
- BMJ: Oral HRT More Than Doubles the Risk of Blood Clots
- OSI Pharmaceuticals to Provide a Summary of Data Presented at the 2008 American Society of Clinical Oncology Meeting
- Node-negative early stage breast cancer patients benefit from Taxotere-based chemotherapy
- Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results from New Parkinson's Study at International Stem Cell Meeting in Tel Aviv
- Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere-Based Chemotherapy
- Innate Pharma Announces Phase Iia Results with IPH 1101 as Second Line Monotherapy in Metastatic Renal Cell Carcinoma
- Synairgen present data regarding barrier function-improving peptide at ATS
- TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
- Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World
- Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions
May 28, 2008
- NanoViricides in Discussions with Pharma about EKC Eye Drug Candidate
- Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
- Study Showed Alimta (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
- Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator
- Amgen Announces Webcast to Discuss Results of Denosumab Phase 3 Head-to-Head Study Versus Alendronate at the Upcoming European Symposium on Calcified Tissues Conference
- Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
- Santhera Presents Efficacy Data of SNT-317 in Congenital Muscular Dystrophy at International Congress of Myology
- Oculus Innovative Sciences Announces Publication of Microcyn Technology Post-Caesarean Section Wound Study in Indian Medical Gazette
- Phase III Clinical Study Using BSD Medical's Systems for Treating Pancreatic Cancer to Be Announced at ASCO
- Astex Drug Candidates to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting
- Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (Fosamax)
- GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting
- Advexin Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
- ImmunoCellular Therapeutics Announces Ability to Characterize Distinct Antigens Between Cancers Using Monoclonal Antibody Technology
- Access Pharmaceuticals Presents New Data on the Company's Cobalamin Technology at an International Polymer Therapeutics Symposium
- Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac Development at Prestigious International Symposium
- Nymox Reports Significant Long-Term Improvement in BPH Symptoms After NX-1207 Treatment in New Multi-Center U.S. Study
- Gene Therapy Increases Survival for End-Stage Head and Neck Cancer
May 29, 2008
- Reduction of Pain, Itching, and Rash Shown in Study of Oncology Patients by MPM Medical, Inc., Subsidiary of RBC Life Sciences
- Novadaq Updates on Optix Data Reported at Euroretina
- Repros Therapeutics Inc. Announces That Initial Findings for Proellex Show No Adverse Effects on the Endometrium after One Year on Drug
- EpiCept Announces Presentation of EPC2407 Data at 2008 American Society of Clinical Oncology Annual Meeting
- Alfacell Corporation Announces Preliminary Results From Onconase Phase IIIb Clinical Trial
- BrainStorm Cell Therapeutics NTF Cells Shows Significant Advantage in Pre-Clinical Study for Parkinson's Disease
- Arenegyr: Key Preliminary Results of Phase II Trials in Mesothelioma and Colorectal Cancer Presented at ASCO
- Long-Term Followup in Phase 3 CLL Trial Shows Genasense is Associated with Significantly Increased Survival in All Responders
- Strativa Pharmaceuticals Announces Preliminary Results from Onconase Phase IIIb Clinical Trial
- EpiCept Announces Presentation of EPC2407 Data at 2008 American Society of Clinical Oncology Annual Meeting
- GenVec Presents Encouraging Data on TNFerade in Esophageal Cancer
- New England Journal of Medicine Publishes Results From a Relistor Phase 3 Clinical Study
- Data from Pivotal Phase III Studies of Gilead's Letairis (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
- Cleviprex(TM) Reduces and Controls Acutely Elevated Blood Pressure in Elderly Patients, According to New Analysis from VELOCITY Trial
- Introgen Presents Top Line Data from Phase III Advexin Clinical Trial
- Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant And Sustained Improvement in Diarrhea-Associated Irritable Bowel Syndrome (d-IBS)
- Cellceutix Cancer Compound: Crunching the Numbers
- Advexin Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
- Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients
- LifeCycle Pharma to Present Data at American Transplant Congress (ATC) in Toronto
- Graceway Pharmaceuticals Reports Study in Journal of Pediatrics: Atoplclair is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children
- Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
May 30, 2008
- Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
- PTC124 Featured at Third Annual Congress of Myology
- NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
- Phase III Data on BEMA Fentanyl to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
- Presentation of Data on Progen's Cancer Epigenetic Targets Platform
- AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
- Two Doxil Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
- Participants in TCA Cellular Therapy's Stem Cell Protocol Experiencing Remarkable Results
- Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
- Data from Clinical Trial of MediGene's EndoTAGTM-1 in the Indication Pancreatic Cancer Will be Presented at ASCO Annual Meeting
- Antisoma Announces Positive ASA404 Presentations at ASCO
- Vion Pharmaceuticals to Present Clinical Data on Cloretazine (VNP40101M) at the ASCO Annual Meeting
- Continuing Herceptin Treatment Prevents Disease Progression in Women with Aggressive Metastatic Breast
- Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
- AmpliMed Corporation to Present Clinical Data from Three Clinical Trials of Amplimexon at American Society of Clinical Oncology Annual Meeting
- Genasense Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
- Data from Clinical Trial of MediGene's EndoTAGTM-1 in the Indication Pancreatic Cancer will be presented at ASCO Annual Meeting
- Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
- New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
- Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
- Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
- VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data
- Argos Therapeutics Presents Data on the Mechanism of Immunosuppression by Soluble CD83 at the American Transplant Congress
- Clavis Pharma ASA To Present Phase I Clinical Results from Elacyt In Patients with Cancers of the Blood
- Side Effects of Sunitinib in Kidney Cancer are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon
- Immunicon Corporation to Present at 2008 ASCO Annual Meeting
- Nymox Announces New Clinical Trial Data Presentation on BPH Drug at Upcoming American Urological Association Meeting
- Welchol Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
- Pfizer Oncology ASCO 2008 Media Briefing to Discuss Study Results in Broad Range of Cancers
- Spontaneous Mutations Rife in Non-familial Schizophrenia
- About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO
- BioAlliance Pharma Presents New Results on its AMEP Anti-invasive Biotherapy
